Roswell Park Logo - no background
American Cancer Society 2023 - no background

Liver and Lung Cancer Webinar Series

Claim your credits

A paved terrace with garden boxes

All healthcare providers are welcome to join these two webinar sessions to learn more information on lung and liver cancer symptoms. The goal is to provide attendees with the necessary tools to engage patients in preventative, routine screening conversations, utilizing targeted, culturally sensitive messages, and evidence-based interventions.

Educational objectives

  • Describe and explain lung and liver cancer screening protocols/guidelines.
  • Perform targeted and culturally sensitive conversations with patients about cancer symptoms, testing strategies and evidence-based interventions.
  • Reduce barriers to screening and provide equitable access to cancer care.

Empowering YOU to discuss liver cancer: A webinar for primary care teams

Wednesday, May 17, 2023
12:00 - 1:00 p.m.

Claim your credit

This webinar focuses on providing clinicians and care teams with education on liver cancer symptoms so that they engage patients in preventive routine screening conversations utilizing targeted, culturally responsive evidence-based interventions. A secondary goal is to increase knowledge about screening protocols and survivorships issues and to increase awareness about the burden of liver cancer incidence and mortality.

Registration fees: Gratis

Presenters
Renuka Iyer, MD
Professor of Oncology
Department of Medicine
Roswell Park Comprehensive Cancer Center
Kristen Spencer, DO, NYU Langone Perlmutter Cancer Center, webinar speaker
Assistant Professor of Oncology
Department of Medicine
NYU Grossman School of Medicine
 

Accreditation Council for Continuing Medical Education (ACCME)

Roswell Park Comprehensive Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. This live-streamed educational activity is designated for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Saving lives through new developments in lung cancer screenings: A webinar for primary care teams

Thursday, June 15, 2023
12:00 - 1:00 p.m.

Claim your credit

The webinar focuses on providing clinicians and care teams with education on lung cancer symptoms so that they engage patients in preventive routine screening conversations utilizing targeted, culturally responsive evidence-based interventions. A secondary goal is to increase knowledge about screening protocols and survivorships issues and to increase awareness about the burden of lung cancer incidence and mortality.

Registration fees: Gratis

Presenters
Mary Reid, MSPH, PhD
Chief of Cancer Screening, Survivorship and Mentorship
Roswell Park Comprehensive Cancer Center
Patrick Ma, MD, MSc, Penn State Cancer Institute
Professor of Oncology
Department of Medicine
Penn State Cancer Institute

Accreditation Council for Continuing Medical Education (ACCME)

Roswell Park Comprehensive Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. This live-streamed educational activity is designated for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial disclosures

Speakers
Dr. Renuka Iyer is a speaker for Intellisphere
Dr. Mary Reid is a researcher and advisor for Johnson & Johnson
Dr. Kristen Spencer is an advisor for Caris Life Sciences
Dr. Patrick Ma is on the advisory board of AstraZeneca and BeiGene. He is also a researcher for AbbVie, Apollomics, Genmab, Mirati Therapeutics, and OncoC4.

CME Advisory Committee
Dr. Elizabeth Griffiths is on the advisory board of AbbVie, Alexion Pharmaceuticals/AstraZeneca Rare Disease, Apellis, Genentech, Picnic Health, Taiho Oncology. She receives honoraria and/or research funding from Astex Pharmaceuticals, Blueprint Medicines, American Society of Hematology, AAMDS Foundation, MDS International Foundation, and Dresner Foundation.

***

None of the speakers, planners, and CME Advisory Committee members, who were not already listed, had any relevant financial relationships with ineligible companies within the previous 24 months. All relevant financial relationships with commercial companies have been mitigated.